Our Future Ambitions

Aerial view of a bridge spanning a deep blue river gorge with rocky cliffs and green vegetation on both sides.
17 September 2024
CHAPTER 9 . OUR FUTURE OUTLOOK

Our Future Ambitions

Words by

Close-up of nicotine products: a green Velo pouch container labeled 'Bright Spearmint' and a blue vaping device against a colorful background.

As we enter the second decade of our transformation, we have re-articulated our ambitious plans to create A Better Tomorrow™ through Building a Smokeless World. Our aim is to become a high-growth, global consumer goods company: consumer-centric, multi-category, with sustainability at our core. We believe A Better Tomorrow™ will be enabled by our lower risk profile, Smokeless Products that deliver public health benefits via Tobacco Harm Reduction (THR), and our parallel strategy to explore opportunities beyond nicotine.

Sign up for more exclusive the Omni™ content

Tobacco Harm Reduction

As we move forward, we want to continue to build momentum. We have clear internal goals, as well as five global stakeholder needs, that are essential to successfully delivering our ambition: 

 

Internal goals

  • Continue the research to support the THR potential of our Smokeless Products
  • Set new expectations for relationships with regulators, public health, and scientific stakeholders
  • Continue to publish our studies in peer reviewed scientific journals
  • Creation of internal global guidelines that advance THR by restricting underage access and usage of Smokeless Products

Global stakeholder needs

  • A global regulatory framework that supports both tobacco control and THR as part of their public health strategy on tobacco and nicotine
  • Accurate communication from public health and regulatory authorities on the risk profile of Smokeless Products relative to smoking
  • Accurate communication from public health and regulatory authorities on the risk profile of nicotine
  • All markets around the world make Smokeless Products available
  • A global regulatory framework that is aligned with the pace of innovation in Smokeless Products
     

Progress has been evident from the first decade of our transformation, in terms of transitioning a significant portion of our legacy cigarette business to our Smokeless Products business. Today, Smokeless Products account for more than 16.5% of our total revenues. This part of our business became profitable in 2023, two years ahead of schedule. Additionally, in 25 of our 82 global Smokeless Products markets, >30% of the total revenues in those markets are from Smokeless Products, demonstrating the THR penetration within those markets.

 

Our Smokeless Products’ contribution to global THR is significant. We have the second largest number of Smokeless Product adult consumers, demonstrating that our multi-category portfolio approach is actively encouraging adult smokers who would otherwise continue to smoke to switch (Figure 1).

Figure 1. Cross Industry comparison of progress on THR*

Figure 1. Cross Industry comparison of progress on THR*

Our decade of transformation:

23.9m

consumers of our Smokeless Products

16.5%

of total revenues of BAT accounts for Smokeless Products

82

markets in which our Smokeless Products are available

Beyond Nicotine

Alongside our Tobacco Harm Reduction strategy, our future growth accelerator, Beyond Nicotine, was launched in 2021. With Beyond Nicotine we will build a pathway to a new portfolio of non-nicotinebased products that can enhance BAT's future growth. We have clear internal goals but also global stakeholder needs that are essential to our ambition:

 

Internal goals

  • Create a second engine of innovation in Beyond Nicotine
  • Create a global science and innovation ecosystem that enables the creation of a consumer-inspired product portfolio
  • Creation of a science programme to understand critical principles of safety, quality and efficacy of our new Beyond Nicotine innovations

Our Beyond Nicotine growth accelerator is key to our transformation to become a high-growth, global consumer goods company. We aim to provide even more choice in new and exciting areas of product innovation and meet the evolving needs of adult consumers, through exploring opportunities beyond nicotine, such as 'Wellbeing & Stimulation'.

 

Our global wellbeing brand 'Ryde' focuses on promoting both wellbeing and stimulation. This range of bioactivebased products is designed to be used by adult consumers throughout the day for specific moments, to improve focus, to boost energy or to relax. To ensure these products are scientifically substantiated in terms of the benefits they provide, we created Ryplenish™ – a scientifically assessed formula designed to deliver the mood state as per the product claim.

 

We are assessing the market potential of Ryde with pilot tests in Australia, Canada, and the U.S. Early data suggests that there is significant commercial and consumer relevance with Ryde.

 

We are in the initial phases of our Beyond Nicotine journey and are making significant investments in a global science and innovation ecosystem. This will enable us to leverage our strengths, as well as to develop new ones, in order to better meet the needs of the consumers of tomorrow.

A representation of our vision to create A Better Tomorrow™ through Building a Smokeless World and our parallel strategy to explore opportunities beyond nicotine. 

 

A Better Tomorrow™

A Smokeless World enabled by Tobacco Harm Reduction

Moving forward

We are making significant progress on transitioning our business from cigarettes to Smokeless Products, driving our ambition of reducing the health impact of our business via Tobacco Harm Reduction.

 

Looking to the future

To accelerate the next phase of our transformation, we are committing to Building a Smokeless World - sustainably, responsibly and with integrity. We will continue to engage and collaborate with a broad range of stakeholders on the public health opportunity presented by Tobacco Harm Reduction while we invest in the science and the right multi-category portfolio to actively encourage smokers to switch to Smokeless Products. In turn, this will realise the multi-stakeholder benefits of A Better Tomorrow™.

Table 1. Enterprise metrics for our transition

Table 1. Enterprise metrics for our transition

Tadeu Marroco
17 September 2024
Chief Executive

Tadeu Marroco

"We have before us a real opportunity to create A Better Tomorrow™ by Building a Smokeless World - the potential to benefit society while providing better options for our consumers and creating a sustainable business for the future."

 

 

Paul McCrory
17 September 2024
Director, Corporate & Regulatory Affairs

Paul McCrory

"Regulators, the public health community and manufacturers like BAT play crucial roles in maximising the potential of Tobacco Harm Reduction. With the right policies in place, and with every adult smoker given the option to choose whether and how to continue using nicotine, we can Build a Smokeless World and reduce the health impact of our business."

Kingsley Wheaton
17 September 2024
Chief Strategy & Growth Officer

Kingsley Wheaton

"Our vision is to create a future where a wide range of innovative Smokeless Products is accessible to adult smokers, advancing Tobacco Harm Reduction and providing sustainable growth on the path to A Better Tomorrow™."

James Murphy
17 September 2024
Director, Research & Science

James Murphy

"I am proud to have been part of BAT’s transformation journey since day one, and there is no place I would rather be, contributing to Tobacco Harm Reduction on a global scale and Building a Smokeless World."


Footnotes

* Total number of Smokeless Product (Heated Products, Vapour Products, Oral Tobacco Products, and Oral Nicotine Pouches) consumers, 2023 (millions)

Check out our other Omni™ chapters